229000 — Gencurix Income Statement
0.000.00%
- KR₩43bn
- KR₩41bn
- KR₩3bn
Annual income statement for Gencurix, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 137 | 1,572 | 3,047 | 2,559 | 2,600 |
Cost of Revenue | |||||
Gross Profit | 8.07 | -1,250 | -2,978 | 1,158 | 1,348 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 9,249 | 9,653 | 15,514 | 16,714 | 13,746 |
Operating Profit | -9,113 | -8,081 | -12,467 | -14,154 | -11,146 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -9,162 | 32,966 | -35,150 | -25,452 | -20,295 |
Provision for Income Taxes | |||||
Net Income After Taxes | -9,162 | 32,964 | -35,149 | -25,451 | -20,139 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -9,162 | 33,108 | -34,670 | -24,597 | -19,260 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -9,162 | 33,108 | -34,670 | -24,597 | -19,260 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1,111 | 4,910 | -4,866 | -2,560 | -1,625 |
Dividends per Share |